Thymidylate synthetase inhibitors and fragile site expression in lymphocytes.
The ability of three thymidylate synthetase inhibitors, fluorodeoxyuridine, fluorodeoxycytidine, and trifluorothymidine, to induce the expression of eight different folate-sensitive fragile sites has been investigated in 22 patients and compared with the efficacy of simple folate deprivation for inducing fragile site expression. Fluorodeoxyuridine and fluorodeoxycytidine were equal in their ability to elicit fragile site expression but fluorodeoxycytidine proved less cytotoxic under comparable culture conditions. Both fluorodeoxyuridine and fluorodeoxycytidine were found to be more efficient than trifluorothymidine at comparable concentrations but less efficient than simple folate deprivation in eliciting fragile site expression in lymphocytes. Since the three inhibitors induced expression of eight different folate-sensitive fragile sites, it is likely that all folate-sensitive fragile sites have a common underlying mechanism of expression. The practical application of thymidylate synthetase inhibitors in the routine detection of heritable fragile sites is discussed.
D000293:Adolescent; D000328:Adult; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D003470:Culture Media; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D005467:Floxuridine / Q000494:pharmacology; D005492:Folic Acid / Q000502:physiology; D005600:Fragile X Syndrome / Q000201:enzymology / Q000235:genetics*; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D008780:Methyltransferases / Q000037:antagonists & inhibitors*; D008875:Middle Aged; D012729:Sex Chromosome Aberrations / Q000235:genetics*; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors*; D014271:Trifluridine / Q000494:pharmacology
D003470:Culture Media; D005467:Floxuridine; D003841:Deoxycytidine; D005492:Folic Acid; D008780:Methyltransferases; D013940:Thymidylate Synthase; C007746:5-fluoro-2'-deoxycytidine; D014271:Trifluridine